findmyKOL
Clinical trialNCT06797336RecruitingPhase 1Interventional

A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors

SponsorPAQ Therapeutics, Inc.Enrollment115Solid Tumor
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Dana Farber/massachusetts General Hospital, Inc

    Boston, Massachusetts, United States

    Leon Pappas
    Recruiting
  • Scri Lake Mary

    Nashville, Tennessee, United States

    Recruiting
  • Scri Oncology Partners

    Nashville, Tennessee, United States

    Recruiting
  • New Experimental Therapeutics of San Antonio Llc

    San Antonio, Texas, United States

    Dr. Anthony Tolcher
    Recruiting
  • Start - South Texas Accelerated Research Therapeutics, Llc

    San Antonio, Texas, United States

    Dr. Drew Rasco
    Recruiting
  • Start Mountain Region

    West Valley City, Utah, United States

    Dr. William McKean
    Recruiting
  • Next Virginia

    Fairfax, Virginia, United States

    Alexander Spira
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PT0253
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Dec 2024
Primary completion
15 Dec 2026
Completion
16 Jun 2027
Last update posted
18 Dec 2025
Registered enrollment
115
Registry id
NCT06797336

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.